Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

MLC 901 Decreases HSP-70, MMP-9, Cerebral Infarction Volume and Functional Outcome in Acute Ischemic Stroke Rat Model

The Indonesian Biomedical Journal · Vol. 17 No. 3 (2025) · hlm. 252–262

DOI
10.18585/inabj.v17i3.3610
ISSN
2085-3297, 2355-9179
Terbit
2025-06-17
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Acute ischemic stroke (AIS) is usually treated with thrombolysis, however the percentage of patients receiving this therapy is not quite low. Therefore, it is necessary to find alternative therapy using neuroprotective agent such as Moleac (MLC) 901. Heat shock proteins (HSP)-70 and matrix metalloproteinase (MMP)-9 are usually related to AIS due to the triggered stroke-induced physiological stress. However, the effect of MLC 901 on Hsp70 mRNA expression, HSP-70 and MMP-9 remains unclear. This study was conducted to determine the effect of MLC 901 on those three parameters in relation to cerebral infarction volume and functional outcomes in an AIS model.METHODS: Rats were induced with AIS using unilateral common carotid artery occlusion (UCAO) and received three different treatments: 43.2 mg/200 gBW MLC 901, 21.6 mg/200 gBW MLC 901, and sodium carboxymethyl cellulose (CMC-Na), that were administered orally for 14 days. HSP-70 and MMP-9 protein levels were assessed using enzyme-linked immunosorbent assay (ELISA), and Hsp70 mRNA expression was assessed using quantitative real-time polymerase chain reaction (qRT-PCR). Foot fault scores for evaluation functional outcome and infarction volume were assessed by ImageJ.RESULTS: AIS-induction increased HSP-70, MMP-9, and Hsp70 mRNA expression within 24-48 h. MMP-9, HSP-70, and Hsp70 mRNA expression were reduced by MLC 901. MLC 901 at dose of 43.2 mg/200 gBW and 21.6 mg/200 gBW were effective in reducing these levels compared to the control. MLC 901 improved functional outcomes and decreased cerebral infarction volume. Moreover, a dosage of 43.2 mg/200 gBW was more effective in reducing Hsp70 mRNA expression and HSP-70, improving functional outcomes, and reducing cerebral infarction volume than a dosage of 21.6 mg/200 gBW, but not MMP-9 protein.CONCLUSION: MLC 901 effectively decreased Hsp70 mRNA expression, HSP-70 and MMP-9 protein levels, infarct volume, and functional outcomes. MLC 901 could be a potential therapeutic agent for AIS.KEYWORDS: MLC 901, HSP-70, MMP-9, acute ischemic stroke

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 120 tautan kepenulisan bersama · 27 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Hasanuddin University
  • University of Mataram
  • Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo
  • Universitas Airlangga
  • Pelita Harapan University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Bachtiar MurtalaHasanuddin University6
Rahmad MulyadiRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo5
Eka SusantoRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo5
Rina MasadahHasanuddin University4
Budu BuduHasanuddin University3
Irawan YusufHasanuddin University2
Eka Julianta WahjoepramonoPelita Harapan University2
Cahyono KaelanHasanuddin University2
Hamsu KadriyanUniversity of Mataram2
Fakhriawan Fathu RahmanHasanuddin University1
Tammasse TammasseHasanuddin University1
Iin Fadhilah UtamiHasanuddin University1
Rosana AgusHasanuddin University1
A SabranHasanuddin University1
Sri WahyunAfiliasi tidak diketahui1
Nur AfiahHasanuddin University1
Mansyur AriefHasanuddin University1
Sri AsriyaniHasanuddin University1
Nur Amelia BachtiarHasanuddin University1
Irawaty DjaharuddinHasanuddin University1
Nikmatia LatiefHasanuddin University1
Andi IhwanHasanuddin University1
Firdaus HamidHasanuddin University1
Kenny Edward YapAfiliasi tidak diketahui1
Junus Asiu Bulu BaanHasanuddin University1
Muhammad Husni CangaraHasanuddin University1
Upik Anderiani MiskadHasanuddin University1
Zainab AzisHasanuddin University1
Syarifuddin WahidHasanuddin University1
Nita MarianaHasanuddin University1
Jane Magdalena KalatikuAfiliasi tidak diketahui1
Berti Julian NelwanHasanuddin University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">MLC 901 Decreases HSP-70, MMP-9, Cerebral Infarction Volume and Functional Outcome in Acute Ischemic Stroke Rat Model</dc:title><dc:creator>Ilsa Hunaifi</dc:creator><dc:creator>Andi Kurnia Bintang</dc:creator><dc:creator>Jumraini Tammasse</dc:creator><dc:creator>Isra Wahid</dc:creator><dc:creator>Mochammad Hatta</dc:creator><dc:creator>Andi Asadul Islam</dc:creator><dc:creator>Andi Alfian Zainuddin</dc:creator><dc:creator>Paulus Sugianto</dc:creator><dc:subject>acute ischemic stroke</dc:subject><dc:subject>neuroprotection</dc:subject><dc:subject>HSP70</dc:subject><dc:subject>MMP-9</dc:subject><dc:subject>cerebral infarction volume</dc:subject><dc:subject>functional outcome</dc:subject><dc:subject>heat shock proteins</dc:subject><dc:subject>HSP70 mRNA expression</dc:subject><dc:subject>carotid artery occlusion</dc:subject><dc:subject>dose-dependent effects</dc:subject><dc:subject>rat stroke model</dc:subject><dc:subject>cerebral edema</dc:subject><dc:description xml:lang="en">BACKGROUND: Acute ischemic stroke (AIS) is usually treated with thrombolysis, however the percentage of patients receiving this therapy is not quite low. Therefore, it is necessary to find alternative therapy using neuroprotective agent such as Moleac (MLC) 901. Heat shock proteins (HSP)-70 and matrix metalloproteinase (MMP)-9 are usually related to AIS due to the triggered stroke-induced physiological stress. However, the effect of MLC 901 on Hsp70 mRNA expression, HSP-70 and MMP-9 remains unclear. This study was conducted to determine the effect of MLC 901 on those three parameters in relation to cerebral infarction volume and functional outcomes in an AIS model.METHODS: Rats were induced with AIS using unilateral common carotid artery occlusion (UCAO) and received three different treatments: 43.2 mg/200 gBW MLC 901, 21.6 mg/200 gBW MLC 901, and sodium carboxymethyl cellulose (CMC-Na), that were administered orally for 14 days. HSP-70 and MMP-9 protein levels were assessed using enzyme-linked immunosorbent assay (ELISA), and Hsp70 mRNA expression was assessed using quantitative real-time polymerase chain reaction (qRT-PCR). Foot fault scores for evaluation functional outcome and infarction volume were assessed by ImageJ.RESULTS: AIS-induction increased HSP-70, MMP-9, and Hsp70 mRNA expression within 24-48 h. MMP-9, HSP-70 , and Hsp70 mRNA expression were reduced by MLC 901. MLC 901 at dose of 43.2 mg/200 gBW and 21.6 mg/200 gBW were effective in reducing these levels compared to the control. MLC 901 improved functional outcomes and decreased cerebral infarction volume. Moreover, a dosage of 43.2 mg/200 gBW was more effective in reducing Hsp70 mRNA expression and HSP-70, improving functional outcomes, and reducing cerebral infarction volume than a dosage of 21.6 mg/200 gBW, but not MMP-9 protein.CONCLUSION: MLC 901 effectively decreased Hsp70 mRNA expression, HSP-70 and MMP-9 protein levels, infarct volume, and functional outcomes. MLC 901 could be a potential therapeutic agent for AIS.KEYWORDS: MLC 901, HSP-70, MMP-9, acute ischemic stroke</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2025-06-17</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v17i3.3610</dc:identifier><dc:identifier>10.18585/inabj.v17i3.3610</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 17 No 3 (2025); 252-262</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/3610/775</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>